Clinical Trial: Evaluation of Fibroscan(R) Performance in Diagnosing Acute Heart Failure in Patients Presenting to the Emergency Department

U.S., March 5 -- ClinicalTrials.gov registry received information related to the study (NCT07449377) titled 'Evaluation of Fibroscan(R) Performance in Diagnosing Acute Heart Failure in Patients Presenting to the Emergency Department' on Feb. 27.

Brief Summary: Acute heart failure (AHF) is a major cause of acute dyspnea in emergency departments (EDs), driven primarily by venous congestion, which can lead to hepatic congestion and risk of subsequent liver dysfunction. Current diagnostic tools include clinical evaluation, biomarkers, and imaging (Chest X-Ray or echography), are often limited by delayed results, variability, and suboptimal accuracy in emergency settings.

Fibroscan(R), a non-invasive device originally designed to assess liver ...